Recombinant HHY1 is commercially produced in E. coli as a His-tagged fusion protein (1–102 aa) for research applications. Key characteristics include:
| Parameter | Value |
|---|---|
| Source | E. coli |
| Tag | N-terminal His-tag |
| Length | Full-length (1–102 aa) |
| Purity | >90% (SDS-PAGE verified) |
| Storage Buffer | Tris/PBS-based buffer, 6% trehalose, pH 8.0 |
| Applications | SDS-PAGE, protein interaction studies |
| Supplier Examples | MyBioSource.com ($1,150), Creative BioMart (RFL5513SF) |
HHY1’s role remains poorly characterized, but genetic studies link it to vacuolar defects. Mutants lacking HHY1 exhibit hypersensitivity to hygromycin B (25 µg/mL), rapamycin, and caffeine, suggesting impaired vacuolar trafficking or TOR pathway regulation .
Protein interaction networks from STRING highlight potential partners:
| Partner | Function | Interaction Score |
|---|---|---|
| ZRG8 | Zinc-regulated mitochondrial protein | 0.604 |
| VAM10 | Vacuole morphogenesis and fusion | 0.515 |
| SRD1 | Pre-rRNA processing | 0.489 |
| SOM1 | Mitochondrial inner membrane peptidase | 0.422 |
Interactions inferred from co-occurrence and coexpression data .
HHY1 mutants are primarily used to study vacuolar trafficking and antibiotic resistance:
Vacuolar Defects: hhy1 mutants show impaired vacuole fusion/fission, linking vacuolar dysfunction to hygromycin B sensitivity .
Genomic Screens: HHY1 was identified in a screen for genes causing severe hygromycin B hypersensitivity, alongside VPS34 and ARF1 .
TOR Pathway Sensitivity: hhy1 mutants show enhanced sensitivity to rapamycin, implicating TOR signaling in vacuolar homeostasis .
While not directly involved in protein secretion optimization, studies on S. cerevisiae secretory pathways (e.g., IRE1 overexpression) provide context for engineered strain development .
Mechanistic Role: HHY1’s precise function in vacuolar trafficking remains unclear, requiring targeted biochemical assays.
Therapeutic Relevance: Hypersensitivity to hygromycin B in hhy1 mutants could inform antibiotic resistance studies in pathogenic fungi.
Protein Engineering: Recombinant HHY1 may serve as a tool for studying vacuolar protein localization or trafficking pathways.
STRING: 4932.YEL059W
When designing experiments for initial HHY1 expression studies, a systematic approach following established experimental design principles is crucial. Begin by clearly defining your independent variable (typically HHY1 expression levels) and dependent variable (such as cell growth rates, protein yield, or hygromycin-B resistance) . For valid results, implement the following experimental design framework:
Establish a control group using wild-type S. cerevisiae without HHY1 modifications
Create treatment groups with varying HHY1 expression levels
Maintain identical growth conditions across all experimental groups
Measure outcomes at predetermined time points (24h, 48h, 72h)
Include technical and biological replicates (minimum n=3 for each)
This design allows for robust statistical analysis while controlling for extraneous variables such as temperature fluctuations, media composition, and growth phase differences .
The selection of an appropriate strain background significantly impacts experimental outcomes in HHY1 studies. Based on systematic protein expression optimization research, the following strains demonstrate differential suitability:
| Strain Background | Advantages | Limitations | Recommended Applications |
|---|---|---|---|
| BY4741 | Well-characterized knockout collections available, established secretory pathway | Moderate protein yield | Genetic pathway studies, screening experiments |
| W303 | Higher protein expression capacity | Fewer available genetic tools | High-yield protein production |
| S288C | Fully sequenced genome, genetic stability | Lower transformation efficiency | Long-term studies, genomic integration |
| Industrial strains | Robust growth, stress tolerance | Less characterized genetically | Scale-up applications |
For initial characterization studies, the BY4741 background is particularly valuable due to the availability of systematic knockout collections of secretory pathway genes that can be leveraged to optimize HHY1 expression .
Verification of successful HHY1 expression requires a multi-method approach to ensure both accuracy and reliability. Implement the following verification protocol:
Molecular verification:
PCR confirmation of genomic integration
RT-qPCR for transcriptional activity quantification
Sanger sequencing to confirm sequence integrity
Protein expression verification:
Western blot analysis using anti-HHY1 antibodies
GFP-fusion protein visualization (if using a reporter construct)
Mass spectrometry for definitive protein identification
Functional verification:
Hygromycin-B resistance assay with concentration gradient (50-500 μg/ml)
Growth curve analysis in selective media
This comprehensive verification approach aligns with established protocols for recombinant protein expression in yeast systems and ensures confidence in your experimental system before proceeding to more complex analyses .
Systematic optimization of protein secretory pathways can significantly improve HHY1 expression in S. cerevisiae. Research has demonstrated that targeted genetic perturbations yield dramatic improvements in recombinant protein expression. The following genetic modifications have shown particular promise:
Gene deletions with positive effects:
Gene overexpressions with positive effects:
Synergistic combinations:
The mechanisms underlying these improvements involve modulation of the unfolded protein response (UPR), ER-associated degradation (ERAD), and protein folding processes, which collectively enhance the cell's capacity to produce and process recombinant HHY1.
Developing an effective high-throughput screening system requires careful integration of molecular biology techniques with data analytics approaches. The following methodology provides a framework for comprehensive screening:
Library construction:
Reporter system design:
Construct HHY1-GFP fusion proteins for fluorescence-based detection
Implement dual reporters (e.g., GFP and RFP) for normalization of expression levels
Screening procedure:
Miniaturized culture format (96 or 384-well plates)
Automated fluorescence measurement at standardized time points
Hygromycin-B challenge assay for functional validation
Data analysis pipeline:
Implement machine learning algorithms for pattern recognition in large datasets
Utilize statistical methods to identify significant hits
Apply principal component analysis to identify gene clusters with similar effects
This approach enables systematic evaluation of potential genetic targets across the secretory pathway, facilitating discovery of novel factors affecting HHY1 expression beyond the currently known modulators .
Resolving contradictory data in HHY1 expression studies requires a structured analytical approach. When faced with conflicting results, implement this systematic resolution framework:
Methodological reconciliation:
Analyze differences in experimental protocols (growth conditions, media composition, measurement techniques)
Standardize key methodological parameters across studies
Replicate contradictory experiments side-by-side under identical conditions
Statistical reanalysis:
Apply more robust statistical methods (e.g., Bayesian approaches)
Perform meta-analysis when multiple datasets are available
Analyze potential sources of bias or confounding variables
Strain and genetic background assessment:
Verify genetic stability through sequencing
Test expression in multiple strain backgrounds
Control for potential background mutations
Molecular mechanism investigation:
Examine potential post-translational modifications
Analyze protein localization and trafficking
Investigate potential regulatory networks
This systematic approach not only resolves contradictions but often reveals deeper insights into the biological complexity of HHY1 expression regulation in yeast systems .
Post-translational modifications (PTMs) significantly influence HHY1 protein functionality and stability. Understanding these modifications requires a multi-faceted analytical approach:
Identification of key PTMs:
| Modification Type | Detection Method | Functional Impact | Regulation Mechanism |
|---|---|---|---|
| Phosphorylation | MS/MS, PhosphoTag gels | Activity modulation, localization | Kinase/phosphatase pathways |
| Glycosylation | Glycosidase treatment, lectin binding | Folding, stability, secretion | ER processing machinery |
| Ubiquitination | IP-Western, MS | Degradation targeting | ERAD pathway |
| SUMOylation | SUMOylation-specific antibodies | Protein-protein interactions | SUMO ligase activity |
Experimental approaches for PTM analysis:
Site-directed mutagenesis of predicted modification sites
In vitro enzymatic modification assays
Pulse-chase experiments for stability determination
Subcellular fractionation to track modified vs. unmodified protein
Quantitative assessment of PTM impact:
Measure half-life of modified vs. unmodified protein
Determine activity differences between modified forms
Assess localization changes driven by modifications
Quantify binding partner interactions of different PTM states
Understanding these modifications provides crucial insights into regulatory mechanisms controlling HHY1 function and can inform strategies to enhance protein stability and activity through targeted genetic or chemical interventions .
Mathematical modeling of the relationship between HHY1 expression and hygromycin-B resistance provides predictive power and mechanistic insights. Several modeling approaches have demonstrated utility in this context:
Dose-response modeling:
The Hill equation effectively describes the sigmoidal relationship between HHY1 expression and hygromycin-B resistance:
Where R represents resistance level, R_max is maximum resistance, [HHY1] is expression level, EC50 is the HHY1 concentration producing 50% of maximum resistance, and n is the Hill coefficient indicating cooperativity.
Time-dependent models:
Modified Gompertz function for modeling resistance development over time:
Where R(t) is resistance at time t, k is the rate parameter, and λ is the lag time before resistance develops.
Stochastic models:
Markov chain models accounting for cell-to-cell variability in expression:
Where P(j,t) is the probability of state j at time t, and T_i,j is the transition probability from state i to j.
These models can be fitted to experimental data using non-linear regression techniques, and model selection should be guided by Akaike Information Criterion (AIC) or Bayesian Information Criterion (BIC) to identify the most appropriate mathematical representation .
Elucidating the molecular mechanism of HHY1-mediated hygromycin-B resistance requires a comprehensive experimental strategy targeting multiple aspects of cellular function:
Interaction mapping experiments:
Yeast two-hybrid screening to identify HHY1 binding partners
Co-immunoprecipitation coupled with mass spectrometry
Proximity labeling methods (BioID, APEX) for in vivo interaction detection
FRET/BRET analysis for direct physical interactions
Localization and trafficking studies:
Fluorescence microscopy with subcellular markers
Live-cell imaging with time-lapse monitoring
Subcellular fractionation with quantitative western blotting
Electron microscopy for ultrastructural localization
Functional domain mapping:
Systematic truncation and domain swapping experiments
Site-directed mutagenesis of conserved residues
Chimeric protein construction
Heterologous complementation assays
Resistance mechanism characterization:
Ribosome binding and translation inhibition assays
Drug uptake and efflux measurements
Drug modification/inactivation assays
Comparative transcriptomics and proteomics with and without HHY1
This experimental framework allows for systematic interrogation of the mechanistic basis of HHY1-mediated resistance, generating testable hypotheses about functional domains, interaction partners, and cellular pathways involved .
Bioinformatic prediction of mutation impacts on HHY1 function leverages computational tools and evolutionary information to guide experimental work. Implement this comprehensive bioinformatic framework:
Sequence-based predictions:
Multiple sequence alignment across fungal species to identify conserved regions
Calculation of evolutionary conservation scores (e.g., ConSurf analysis)
Prediction of functionally important sites using entropy-based methods
Identification of known functional motifs and domains
Structure-based predictions:
Homology modeling of HHY1 structure
Molecular dynamics simulations of wild-type and mutant proteins
Energy calculation changes (ΔΔG) upon mutation
Protein-protein docking predictions with potential partners
Machine learning approaches:
Random forest classifiers trained on known mutation effects
Support vector machines for stability change predictions
Deep learning networks integrating multiple features
Ensemble methods combining multiple predictors
Systems-level predictions:
Network analysis of HHY1 in protein interaction networks
Pathway enrichment analysis
Flux balance analysis in metabolic models
Gene essentiality predictions in different genetic backgrounds
This multi-layered bioinformatic approach provides prioritization of mutations for experimental validation and generates mechanistic hypotheses about how specific amino acid changes might affect HHY1 function in the context of hygromycin-B resistance .